Oracle Stock Drops 5.92% as Oppenheimer and Piper Sandler Hold Buy Ratings

By TrendSpider Editor

Oracle Corporation is under significant selling pressure today, with shares falling 5.92% to $135.79 as two Wall Street firms reaffirm their bullish stances without moving the needle for investors. Oppenheimer's Brian Schwartz and Piper Sandler's Billy Fitzsimmons both confirmed buy ratings on Thurs

Oracle Stock Drops 5.92% as Oppenheimer and Piper Sandler Hold Buy Ratings

Oracle Corporation is under significant selling pressure today, with shares falling 5.92% to $135.79 as two Wall Street firms reaffirm their bullish stances without moving the needle for investors. Oppenheimer's Brian Schwartz and Piper Sandler's Billy Fitzsimmons both confirmed buy ratings on Thursday, though neither raised their price targets, offering little new ammunition for bulls looking for a catalyst. With ORCL trading near the low end of its 52-week range of $114.50 to $287.00, the gap between current price and analyst targets is growing wider, raising questions about whether the stock is a deep value opportunity or a falling knife.

Key Drivers of the ORCL Stock Move

• Main Catalyst: Two analyst confirmations hit the tape today with no upgrades and no downgrade. Oppenheimer's Brian Schwartz reiterated a buy with a $275 price target, unchanged from prior, while Piper Sandler's Billy Fitzsimmons confirmed a buy at a $225 price target, also unchanged. Neither firm saw fit to adjust their outlook despite today's sharp decline.
• Bull Case: With a consensus average price target of $250 and ORCL currently trading at $135.79, the implied upside from the analyst consensus stands at a substantial premium to current levels. Both confirming firms maintain buy ratings, suggesting conviction in Oracle's longer-term trajectory even amid short-term price deterioration.
• Bear Case: The fact that neither firm raised its price target during a 5.92% single-session drop signals a lack of urgency to defend the stock with fresh conviction. At $135.79, ORCL is trading dramatically below both price targets, which could reflect the market pricing in deteriorating fundamentals that analysts have yet to fully incorporate. The stock is also uncomfortably close to its 52-week low of $114.50.

The forward setup for ORCL is challenging. Today's decline places the stock at levels not seen in much of the past year, and the absence of any upgraded price target or new institutional catalyst from either analyst action leaves the stock without a near-term technical or fundamental floor from the sell-side. The average price target of $250 across the two confirming analysts represents a significant implied recovery, but with no upgrade momentum and two static confirmations, the market appears unconvinced. Investors will be watching closely for any broader commentary on Oracle's cloud infrastructure business or enterprise software demand trends that could shift sentiment in the sessions ahead.

ORCL Analyst Ratings and Price Targets

Two analyst actions were recorded for Oracle today, October 29, 2026, with zero upgrades and zero downgrades:

• Oppenheimer (Brian Schwartz): Confirms buy rating | Price target: $275 (unchanged from prior $275)
• Piper Sandler (Billy Fitzsimmons): Confirms buy rating | Price target: $225 (unchanged from prior $225)

The consensus average price target across both actions stands at $250, reflecting a wide divergence between where analysts believe ORCL should trade and where it is actually trading at $135.79 today.

ORCL Seasonality

Late October has historically been a transitional period for large-cap technology names, with volatility often elevated as investors reposition ahead of year-end. A stock trading near multi-month lows heading into November can face additional seasonal headwinds as tax-loss harvesting activity picks up.

ORCL Relative Performance

Oracle's 5.92% single-session decline is a notable underperformer by any measure, particularly for a mega-cap enterprise software company. With ORCL sitting at $135.79 against a 52-week high of $287.00, the stock has shed more than half its peak value over the trailing year, a drawdown that stands in stark contrast to the broader resilience seen across many large-cap technology peers. The proximity to the 52-week low of $114.50 makes relative performance a key watch point in sessions ahead.